Endologix Inc. (ELGX)
-NasdaqGS 13.57 
0.50(3.83%) Jun 18, 4:00PM EDT
| Prev Close: | 13.07 |
|---|
| Open: | 13.06 |
|---|
| Bid: | N/A |
|---|
| Ask: | 24.97 x 100 |
|---|
| 1y Target Est: | 17.40 |
|---|
| Beta: | 0.95 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 12.95 - 13.57 |
|---|
| 52wk Range: | 11.15 - 16.39 |
|---|
| Volume: | 1,199,425 |
|---|
| Avg Vol (3m): | 503,350 |
|---|
| Market Cap: | 852.17M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.47 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ENDOLOGIX INC /DE/ Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online(Fri, Jun 14)
- Do You Trust the Earnings at Endologix?at Motley Fool(Wed, Jun 12)
- ENDOLOGIX INC /DE/ Files SEC form 8-K, Other EventsEDGAR Online(Mon, Jun 3)
- Endologix's Management Presents at Deutsche Bank 38th Annual Healthcare Conference (Transcript)at Seeking Alpha(Thu, May 30)
- 3 Medical Device Small Caps Trading Below Lowest Target Priceat Seeking Alpha(Thu, May 30)
- Is Endologix's Cash Machine Fast Enough?at Motley Fool(Tue, May 28)
- ENDOLOGIX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online(Fri, May 24)
- Here's Why Endologix's Latest Report Might Worry Youat Motley Fool(Wed, May 22)
- Finding Value in the Medical Products and Device Spaces: An Experienced Portfolio Manager Discusses Investing in Overlooked Health Care AreasWall Street Transcript(Fri, May 17)
- Here's 1 Reason Endologix Looks Weakat Motley Fool(Mon, May 13)
- ENDOLOGIX INC /DE/ FinancialsEDGAR Online Financials(Fri, May 10)
- Endologix to Participate in Three Upcoming Investor ConferencesGlobeNewswire(Wed, May 8)
- Is a Revenue Miss Coming for Endologix?at Motley Fool(Wed, May 8)
- ENDOLOGIX INC /DE/ Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, May 6)
- Endologix Earnings: Here’s Why Investors are Ambivalent Nowat Wall St. Cheat Sheet(Tue, Apr 30)
Key Statistics
| Forward P/E (1 yr): | 113.08 |
|---|
| P/S (ttm): | 7.38 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.15 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.05 |
|---|
| Mean Recommendation*: | 1.6 |
|---|
| PEG Ratio (5 yr expected): | -0.92 |
|---|
Business Summary
Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of aortic disorders. It offers the ELG System, a stent graft and delivery system for the treatment of abdominal aortic aneurysms through minimally-invasiv...
View More